At a scientific meeting in Denver, Colo., doctors who treat Alzheimer's patients are figuring out how they will use the newly approved drug Aduhelm, which has had conflicting evidence of its efficacy.
Subscribe to:
Post Comments
(
Atom
)
Post a Comment